• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

呼吸困难的测量。两种新临床指标的内容、观察者间一致性及生理相关性

The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes.

作者信息

Mahler D A, Weinberg D H, Wells C K, Feinstein A R

出版信息

Chest. 1984 Jun;85(6):751-8. doi: 10.1378/chest.85.6.751.

DOI:10.1378/chest.85.6.751
PMID:6723384
Abstract

To improve the clinical measurement of dyspnea, we developed a baseline dyspnea index that rated the severity of dyspnea at a single state and a transition dyspnea index that denoted changes from that baseline. The scores in both indexes depend on ratings for three different categories: functional impairment; magnitude of task, and magnitude of effort. At the baseline state, dyspnea was rated in five grades from 0 (severe) to 4 (unimpaired) for each category. The ratings for each of the three categories were added to form a baseline focal score (range, 0 to 12). At the transition period, changes in dyspnea were rated by seven grades, ranging from -3 (major deterioration), to +3 (major improvement). The ratings for each of the three categories were added to form a transition focal score (range, -9 to +9). In 38 patients tested with respiratory disease, interobserver agreement was highly satisfactory for both indexes. The baseline focal score had the highest correlation (r = 0.60; P less than 0.001) with the 12-minute walking distance (12 MW), while significant, but lower, correlations existed for lung function. For the transition focal score, there was a significant correlation only with the 12 MW (r = 0.33; p = 0.04). These results indicate that dyspnea can receive a direct clinical rating that provides important information not disclosed by customary physiologic tests.

摘要

为改善呼吸困难的临床测量方法,我们制定了一个基线呼吸困难指数,用于评定单一状态下呼吸困难的严重程度,还制定了一个过渡呼吸困难指数,用于表示相对于该基线的变化。两个指数的评分均取决于对三个不同类别的评级:功能损害;任务量;努力程度。在基线状态下,每个类别中的呼吸困难按从0(严重)到4(无损害)分为五个等级。将三个类别的评级相加,得出基线焦点评分(范围为0至12)。在过渡期间,呼吸困难的变化按七个等级评定,范围从-3(严重恶化)到+3(显著改善)。将三个类别的评级相加,得出过渡焦点评分(范围为-9至+9)。在38例患有呼吸系统疾病的受试患者中,两个指数的观察者间一致性都非常令人满意。基线焦点评分与12分钟步行距离(12MW)的相关性最高(r = 0.60;P < 0.001),与肺功能也存在显著但较低的相关性。对于过渡焦点评分,仅与12MW存在显著相关性(r = 0.33;p = 0.04)。这些结果表明,呼吸困难可以获得直接的临床评级,该评级提供了常规生理测试未揭示的重要信息。

相似文献

1
The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes.呼吸困难的测量。两种新临床指标的内容、观察者间一致性及生理相关性
Chest. 1984 Jun;85(6):751-8. doi: 10.1378/chest.85.6.751.
2
Further specification and evaluation of a new clinical index for dyspnea.一种新的呼吸困难临床指标的进一步细化与评估
Am Rev Respir Dis. 1986 Dec;134(6):1129-34. doi: 10.1164/arrd.1986.134.5.1129.
3
Evaluation of clinical methods for rating dyspnea.评估呼吸困难分级的临床方法。
Chest. 1988 Mar;93(3):580-6. doi: 10.1378/chest.93.3.580.
4
Measurement of respiratory sensation in interstitial lung disease. Evaluation of clinical dyspnea ratings and magnitude scaling.间质性肺疾病中呼吸感觉的测量。临床呼吸困难分级及量表评估。
Chest. 1989 Oct;96(4):767-71. doi: 10.1378/chest.96.4.767.
5
Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者呼吸困难评估临床方法分析
Am J Respir Crit Care Med. 1998 Oct;158(4):1185-9. doi: 10.1164/ajrccm.158.4.9802091.
6
Sustained-release theophylline reduces dyspnea in nonreversible obstructive airway disease.
Am Rev Respir Dis. 1985 Jan;131(1):22-5. doi: 10.1164/arrd.1985.131.1.22.
7
Functional predictors of exertional dyspnea, 6-min walking distance and HRCT fibrosis score in idiopathic pulmonary fibrosis.
Respiration. 2006;73(4):495-502. doi: 10.1159/000089656. Epub 2005 Nov 7.
8
Clinical utility of measures of breathlessness.呼吸急促测量的临床效用。
Respir Care. 2002 Sep;47(9):986-93.
9
Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease.呼吸困难和生理功能对慢性阻塞性肺疾病患者总体健康状况的影响。
Chest. 1992 Aug;102(2):395-401. doi: 10.1378/chest.102.2.395.
10
[Stress studies in pulmonary function diagnosis].
Fortschr Med. 1974 Dec 19;92(35-36):1451-6.

引用本文的文献

1
Dyspnea in Chronic Obstructive Pulmonary Disease: Expert Assessment of Management in Clinical Practice.慢性阻塞性肺疾病中的呼吸困难:临床实践中管理的专家评估
Pulm Ther. 2025 Sep 27. doi: 10.1007/s41030-025-00318-x.
2
The association of symptoms, pulmonary function test and computed tomography in interstitial lung disease at the onset of connective tissue disease: an observational study with artificial intelligence analysis of high-resolution computed tomography.结缔组织病发病时间质性肺疾病的症状、肺功能测试与计算机断层扫描的关联:一项对高分辨率计算机断层扫描进行人工智能分析的观察性研究
Rheumatol Int. 2025 Aug 12;45(9):194. doi: 10.1007/s00296-025-05934-z.
3
T*-weighted oxygen-enhanced pulmonary MRI in COPD is linked to resting and exertional functional measurements.
慢性阻塞性肺疾病(COPD)中基于T*加权的氧增强肺部磁共振成像(MRI)与静息和运动功能测量相关。
BMJ Open Respir Res. 2025 Aug 7;12(1):e002784. doi: 10.1136/bmjresp-2024-002784.
4
Sex-differences in the multidimensional evaluation of dyspnea in respiratory outpatients.呼吸科门诊患者呼吸困难多维评估中的性别差异
Front Med (Lausanne). 2025 Jul 9;12:1627496. doi: 10.3389/fmed.2025.1627496. eCollection 2025.
5
Bisoprolol for patients with chronic obstructive pulmonary disease at high risk of exacerbation: the BICS RCT.比索洛尔用于慢性阻塞性肺疾病急性加重高风险患者:BICS随机对照试验
Health Technol Assess. 2025 May;29(17):1-97. doi: 10.3310/TNDG8641.
6
Relationship Between Dyspnoea Scales and Quality of Life in Stroke Survivors: A Retrospective Analysis.中风幸存者呼吸困难量表与生活质量的关系:一项回顾性分析
Medicina (Kaunas). 2025 Mar 19;61(3):540. doi: 10.3390/medicina61030540.
7
Evaluation of respiratory muscle dysfunction in patients with idiopathic pulmonary fibrosis: a prospective observational study with magnetic resonance imaging.特发性肺纤维化患者呼吸肌功能障碍的评估:一项磁共振成像的前瞻性观察研究。
BMC Pulm Med. 2025 Mar 14;25(1):118. doi: 10.1186/s12890-025-03572-6.
8
Atorvastatin in Severity-Stratified Pulmonary Sarcoidosis: A Phase II Randomized Controlled Trial.阿托伐他汀用于分层严重程度的肺结节病:一项II期随机对照试验。
Am J Respir Crit Care Med. 2025 Mar;211(3):515-518. doi: 10.1164/rccm.202403-0526RL.
9
Real-World and Patient-Reported Outcomes of Dupilumab and Other Biological Drugs for Chronic Obstructive Pulmonary Disease-A Systematic Review.度普利尤单抗及其他生物药物治疗慢性阻塞性肺疾病的真实世界和患者报告结局——一项系统评价
Diagnostics (Basel). 2024 Oct 26;14(21):2390. doi: 10.3390/diagnostics14212390.
10
The occurrence mechanism, assessment, and non-pharmacological treatment of dyspnea.呼吸困难的发生机制、评估及非药物治疗
Med Rev (2021). 2024 Apr 22;4(5):395-412. doi: 10.1515/mr-2024-0006. eCollection 2024 Oct.